US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
FDA Approves Zyn Pouches For Sale As Less Harmful Alternative To Cigarettes
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
FDA bans red dye No. 3 from foods
U.S. regulators are banning the dye called Red 3 from the food supply. The move comes nearly 35 years after the dye was ...
FDA Approves Sale of Zyn Nicotine Pouches as Less Harmful Cigarette Alternative
The Food and Drug Administration officially approved Thursday the sale of wildly popular Zyn nicotine pouches as a less ...
FDA Bans Red No. 3, Leaving 8 Synthetic Dyes In America’s Food
With Wednesday's ban of Red No. 3, there are now 8 artificial dyes in America's food supply. Discover what dyes remain, the ...
Billed as nonaddictive, new pain pill could soon win FDA approval
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
scrippsnews13h
FDA approves sales and marketing for Zyn nicotine pouches
Marketing for the popular nicotine pouch product, Zyn, has been approved by the U.S. Food and Drug Administration to help ...
FiercePharma1d
Government watchdog recommends tweaks to FDA accelerated approval program
The FDA established its accelerated approval program in 1992 to allow drugs to reach the market quickly for life-threatening ...
BioSpace2d
Inspector General Questions FDA’s Accelerated Approval for Biogen, Sarepta Drugs
An OIG report zeroed in on what it said were three particularly problematic accelerated approvals: Biogen’s Aduhelm, ...
BioPharma Dive2d
Federal watchdog cites concerns with FDA’s accelerated approval process
The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...
Monthly Prescribing Reference17h
Tabelecleucel Approval for EBV+ PTLD Delayed; CRL Issued
Tabelecleucel, an allogeneic, EBV-specific T-cell immunotherapy, works by targeting and eliminating EBV-infected cells.
Bryan Johnson discontinues longevity drug, after concerns it may have accelerated aging
Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following ...